Buspirone treatment of anxiety associated with pharyngeal dysphagia in a four-year-old

Journal of Child and Adolescent Psychopharmacology

Volumn 7, Issue 2, 1997, Pages 137-143

  Hanna, Gregory L ^a   Feibusch, Evan L ^a   Albright, Kathie J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BUSPIRONE;

ANXIETY NEUROSIS; ARTICLE; CASE REPORT; DROWSINESS; HUMAN; LARYNGOMALACIA; MALE; PRESCHOOL CHILD; SEPARATION ANXIETY; WEIGHT GAIN;

EID: 12644275424     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1997.7.137     Document Type: Article

References (39)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, D.C., American Psychiatric Press, 1994
2. Balon R: Buspirone in the treatment of separation anxiety disorder in an adolescent boy. Can J Psychiatry 39:581-582, 1994
3. Balster R: Abuse potential of buspirone and related drugs. J Clin Psychopharmacol 10(Suppl):31-37, 1990
4. Barbee JG: Memory, benzodiazepines, and anxiety: Integration of theoretical and clinical perspectives. J Clin Psychiatry 54(Suppl):86-97, 1993
5. 1 receptor agonists and p-chloroamphetamine. Synapse 5:120-133, 1990
6. Cohn JB, Bowden CL, Fisher JG, Rodos JJ: Double-blind comparison of buspirone and clorazepate in anxious outpatients. Am J Med 80(3B):10-16, 1986
7. Cohn JB, Wilcox CS: Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: A double-blind study. J Clin Psychiatry 47:409-412, 1986
8. 1a receptor. In: Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, 1995, pp 1301-1310
9. Di Scipio WJ, Kaslon K, Ruben RJ: Traumatically acquired conditioned dysphagia in children. Ann Otol 87:509-514, 1978
10. Fabre LF: Double-blind comparison of buspirone with diazepam in anxious patients. Curr Ther Res 41:751-759, 1987
11. Gammans RE, Pecknold JC, Smith WT, Rickeis K: Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies. Neuropsychobiology 25:193-201, 1992
12. Goldberg HL, Finnerty RJ: The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry 136:1184-1187, 1979
13. Grady TA, Pigott TA, L'Heureux F, Hill JL, Bernstein SE, Murphy DL: Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder. Am J Psychiatry 150:819-821, 1993
14. Jenkins SW, Robinson DS, Fabre LF, Andary JJ, Messina ME, Reich LA: Gepirone in the treatment of major depression. J Clin Psychopharmacol 10(Suppl):77-85, 1990
15. Kranzler H: Use of buspirone in an adolescent with overanxious disorder. J Am Acad Child Adolesc Psychiatry 27:789-790, 1988
16. Kutcher S, Reiter S, Gardner DM, Klein RG: The pharmacotherapy of anxiety disorders in children and adolescents. Psychiatr Clin North Am 15:41-67, 1992
17. Lader M: Assessing the potential for buspirone dependence or abuse and effects of its withdrawal. Am J Med 82:20-26, 1987
18. Markovitz PJ, Stagno SJ, Calabrese JR: Buspirone augmentation of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry 147:798-800, 1990
19. McDougle CJ, Goodman WK, Leckman JF, Holzer J, Barr LC, McCance-Katz E, Heninger GR, Price LH: Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry 150:647-649, 1993
20. Moskowitz H, Smiley A: Effects of chronically administered buspirone and diazepam on living-related skills performance. J Clin Psychiatry 43:100-102, 1982
21. Munjack DJ, Bruns J, Baltazar PL, Brown R, Leonard M, Nagy R, Koek R, Crocker B, Schafer S: A pilot study of buspirone in the treatment of social phobia. J Anxiety Disord 5:87-98, 1991
22. Napoliello MJ, Domantay AG: Buspirone: A worldwide update. Br J Psychiatry 159(Suppl 12):40-44, 1991
23. Pato MT, Pigott TA, Hill JL, Grover GN, Bernstein S, Murphy DL: Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder. Am J Psychiatry 148:127-129, 1991
24. Pohl R, Balon R, Yeragani VK, Gershon S: Serotonergic anxiolytics in the treatment of panic disorder: A controlled study with buspirone. Psychopathology 22:60-67, 1989
25. Popper CW: Psychopharmacologic treatment of anxiety disorder in adolescents and children. J Clin Psychiatry 54(Suppl):52-63, 1993
26. Robinson DS, Rickels K, Feighner J, Fabre LF, Gammans LE, Shrotriya RC, Alms DR, Andary JJ, Messina ME: Clinical effects of the partial 5-HT1a agonists in depression: A composite analysis of buspirone in the treatment of depression. J Clin Psychopharmacol 10:67S-76S, 1990
27. Rickels K, Schweizer E: The treatment of generalized anxiety disorder in patients with depressive symptomatology. J Clin Psychiatry 54(Suppl):20-23, 1993
28. Schneier FR, Saoud JB, Campeas R, Fallon BA, Hollander E, Coplan J, Liebowitz MR: Buspirone in social phobia. J Clin Psychopharmacol 13:251-256, 1993
29. 1A receptor ligands in animal models of anxiety, impulsivity, and depression: Multiple mechanisms of action? Prog Neuro-Psychopharmacol Biol Psychiatry 17:87-104, 1993
30. Schweizer E, Rickels K: Buspirone in the treatment of panic disorder: A controlled pilot comparison with clorazepate. J Clin Psychopharmacol 8:303, 1988
31. Sheehan DV, Raj AB, Sheehan KH, Soto S: Is buspirone effective for panic disorder? J Clin Psychopharmacol 10:3-11, 1990
32. Simeon JG, Knott VJ, Dubois C, Wiggins D, Geraets I, Thatte S, Miller W: Buspirone therapy of mixed anxiety disorders in childhood and adolescence: A pilot study. J Child Adolesc Psychopharmacol 4:159-170, 1994
33. Smiley A, Moskowitz H: Effects of long-term administration of buspirone and diazepam on driver steering control. Am J Med 80:22-29, 1986
34. Soni P, Weintraub AL: Buspirone-associated mental status changes. J Am Acad Child Adolesc Psychiatry 31:1098-1099, 1992
35. Suzuki M, Uchiumi M, Murasaki M: Effects of buspirone and bromazepam on attention and short-term memory in Japanese healthy volunteers. Jpn J Neuropsychopharmacol 15:453-463, 1993
36. Tunnicliff G: Molecular basis of buspirone's anxiolytic action. Pharmacol Toxicol 69:149-156, 1991
37. Tyrer P, Murphy S, Owen RT: The risk of pharmacological dependence with buspirone. Br J Clin Pract 30(Suppl):91-94, 1985
38. Wolf LS, Glass RP: Feeding and Swallowing Disorders in Infants. Tuscon (AZ), Therapy Skill Builders, 1992
39. Zwier KJ, Rao U: Buspirone use in an adolescent with social phobia and mixed personality disorder (cluster A type). J Am Acad Child Adolesc Psychiatry 33:1007-1011, 1994